Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2

Abstract

The explosion of the new coronavirus (SARS-CoV-2) pandemic has brought the role of the angiotensin converting enzyme 2 (ACE2) back into the scientific limelight. Since SARS-CoV-2 must bind the ACE2 for entering the host cells in humans, its expression and body localization are critical to track the potential target organ of this infection and to outline disease progression and clinical outcomes. Here, we mapped the physiological body distribution, expression, and activities of ACE2 and discussed its potential correlations and mutal interactions with the disparate symptoms present in SARS-CoV-2 patients at the level of different organs. We highlighted that despite during SARS-CoV-2 infection ACE2-expressing organs may become direct targets, leading to severe pathological manifestations, and subsequent multiple organ failures, the exact mechanism and the potential interactions through which ACE2 acts in these organs is still heavily debated. Further scientific efforts, also considering a personalized approach aimed to consider specific patient differences in the mutual interactions ACE2-SARS-CoV-2 and the long-term health effects associated with COVID-19 are currently mandatory.

References 341

1. 1.

   Huang C Wang Y Li X Ren L Zhao J Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. (2020 ) 395:497–506.

   Not in our library10.1016/s0140-6736(20)30183-5

2. 2.

   Chen N Zhou M Dong X Qu J Gong F Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. (2020 ) 395:507–13.

   Not in our library10.1016/s0140-6736(20)30211-7

3. 3.

   Mukherjee R Smith A Sutton R. Covid-19-related pancreatic injury. Br J Surg. (2020 ) 107:e190.

   Not in our library10.1002/bjs.11645

4. 4.

   Lin L Jiang X Zhang Z Huang S Zhang Z Fang Z. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. (2020 ) 69:997–1001.

   Not in our library10.1136/gutjnl-2020-321013

5. 5.

   de-Madaria E Siau K Cárdenas-Jaén K. Increased amylase and lipase in patients with COVID-19 pneumonia: don't blame the pancreas just yet! Gastroenterology. (2020 ).. [Epub ahead of print].

   Not in our library10.1053/j.gastro.2020.04.044

6. 6.
   Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China · 2020

   No notice
7. 7.

   Wu Y Xu X Chen Z Duan J Hashimoto K Yang L. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. (2020 ) 87:18–22.

   Not in our library10.1016/j.bbi.2020.03.031

8. 8.

   Akhmerov A Marban E. COVID-19 and the heart. Circ Res. (2020 ) 126:1443–55.

   Not in our library10.1161/circresaha.120.317055

9. 9.

   Terpos E Ntanasis-Stathopoulos I Elalamy I Kastritis E Sergentanis TN Politou M. Hematological findings and complications of COVID-19. Am J Hematol. (2020 ) 95:834–47.

   Not in our library10.1002/ajh.25829

10. 10.

    Loffredo L Pacella F Pacella E Tiscione G Oliva A Violi F. Conjunctivitis and COVID-19: a meta-analysis. J Med Virol. (2020 ).. [Epub ahead of print].

    Not in our library10.1002/jmv.25938

11. 11.

    Vaira LA Salzano G Fois AG Piombino P De Riu G. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol. (2020 ) 10:1103–4.

    Not in our library10.1002/alr.22593

12. 12.

    Rothan HA Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. (2020 ) 109:102433.

    Not in our library10.1016/j.jaut.2020.102433

13. 13.

    Madjid M Safavi-Naeini P Solomon SD Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. (2020 ) 5:831–40.

    Not in our library10.1001/jamacardio.2020.1286

14. 14.

    Guan WJ Liang WH Zhao Y Liang HR Chen ZS Li YM. China medical treatment expert group for COVID-19. comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. (2020 ) 55:2000547.

    Not in our library10.1183/13993003.00547-2020

15. 15.

    Crackower MA Sarao R Oudit GY Yagil C Kozieradzki I Scanga SE. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. (2020 ) 417:822–8.

    Not in our library10.1038/nature00786

16. 16.

    Hoffmann M Kleine-Weber H Schroeder S Krüger N Herrler T Erichsen S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. (2020 ) 181:271–80.e8.

    Not in our library10.1016/j.cell.2020.02.052

17. 17.

    Turner AJ Hiscox JA Hooper NM. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci. (2004 ) 25:291–4.

    Not in our library10.1016/j.tips.2004.04.001

18. 18.

    Walls AC Park YJ Tortorici MA Wall A McGuire AT Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. (2020 ) 181:281–92.e6.

    Not in our library10.1016/j.cell.2020.02.058

19. 19.

    Glowacka I Bertram S Müller MA Allen P Soilleux E Pfefferle S. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. (2011 ) 85:4122–34.

    Not in our library10.1128/jvi.02232-10

20. 20.

    Wrapp D Wang N Corbett KS Goldsmith JA Hsieh CL Abiona O. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. (2020 ) 367:1260–63.

    Not in our library10.1126/science.abb2507

21. 21.

    Coutard B Valle C de Lamballerie X Canard B Seidah NG Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. (2020 ) 176:104742.

    Not in our library10.1016/j.antiviral.2020.104742

22. 22.
    TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells · 2020

    No notice
23. 23.
    Tumor Necrosis Factor-α Convertase (ADAM17) Mediates Regulated Ectodomain Shedding of the Severe-acute Respiratory Syndrome-Coronavirus (SARS-CoV) Receptor, Angiotensin-converting Enzyme-2 (ACE2) · 2005

    No notice
24. 24.

    Heurich A Hofmann-Winkler H Gierer S Liepold T Jahn O Pöhlmann S. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol. (2014 ) 88:1293–307.

    Not in our library10.1128/jvi.02202-13

25. 25.

    Tipnis SR Hooper NM Hyde R Karran E Christie G Turner AJ. A human homolog of angiotensinconverting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. (2000 ) 275:33238–43.

    Not in our library10.1074/jbc.m002615200

26. 26.

    Komukai K Mochizuki S Yoshimura M. Gender and the renin-angiotensin-aldosterone system. Fundam Clin Pharmacol. (2010 ) 24:687–98.

    Not in our library10.1111/j.1472-8206.2010.00854.x

27. 27.

    World Health Organization Coronavirus Disease (COVID-19) Outbreak. WHO (2020 ). Available online at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019

    Not in our library

28. 28.

    Hamming I Timens W Bulthuis ML Lely AT Navis G van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. a first step in understanding SARS pathogenesis. J Pathol. (2004 ) 203:631–7.

    Not in our library10.1002/path.1570

29. 29.

    Harmer D Gilbert M Borman R Clark KL. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. (2002 ) 532:107–10.

    Not in our library10.1016/s0014-5793(02)03640-2

30. 30.

    Trojanowicz B Ulrich C Kohler F Bode V Seibert E Fiedler R. Monocytic angiotensin-converting enzyme 2 relates to atherosclerosis in patients with chronic kidney disease. Nephrol Dial Transplant. (2017 ) 32:287–98.

    Not in our library10.1093/ndt/gfw206

31. 31.
    High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa · 2020

    No notice
32. 32.

    Uhlén M Fagerberg L Hallström BM. Proteomics. Tissue-based map of the human proteome. Science. (2015 ) 347:1260419.

    Not in our library10.1126/science.1260419

33. 33.

    Cole-Jeffrey CT Liu M Katovich MJ Raizada MK Shenoy V. ACE2 and microbiota: emerging targets for cardiopulmonary disease therapy. J Cardiovasc Pharmacol. (2015 ) 66:540–50.

    Not in our library10.1097/fjc.0000000000000307

34. 34.

    Vargas F Rodríguez-Gómez I Vargas-Tendero P Jimenez E Montiel M. The renin-angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations. J Endocrinol. (2012 ) 213:25–36.

    Not in our library10.1530/joe-11-0349

35. 35.

    Diniz GP Senger N Carneiro-Ramos MS Santos RA Barreto-Chaves ML. Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy. Ther Adv Cardiovasc Dis. (2016 ) 10:192–202.

    Not in our library10.1177/1753944715623228

36. 36.

    Narayan SS Lorenz K Ukkat J Hoang-Vu C Trojanowicz B. Angiotensin converting enzymes ACE and ACE2 in thyroid cancer progression. Neoplasma. (2020 ) 67:402–9.

    Not in our library10.4149/neo_2019_190506n405

37. 37.
    Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy. · 2012

    Not checked
38. 38.

    Alenina N Bader M. ACE2 in brain physiology and pathophysiology: evidence from transgenic animal models. Neurochem Res. (2019 ) 44:1323–9.

    Not in our library10.1007/s11064-018-2679-4

39. 39.

    Wang XL Iwanami J Min LJ Tsukuda K Nakaoka H Bai HY. Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function. NPJ Aging Mech Dis. (2016 ) 2:16024.

    Not in our library10.1038/npjamd.2016.24

40. 40.

    Klempin F Mosienko V Matthes S Villela DC Todiras M Penninger JM. Depletion of angiotensin-converting enzyme 2 reduces brain serotonin and impairs the running-induced neurogenic response. Cell Mol Life Sci. (2018 ) 75:3625–34.

    Not in our library10.1007/s00018-018-2815-y

Cited by papers we hold 1

• Skin Aging, Cellular Senescence and Natural Polyphenols · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.